Press Releases

Month Year

Month Year

Nov 13, 2012

Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment

Read more
Nov 12, 2012

Insmed To Present At Two Upcoming Investor Conferences

Read more
Nov 7, 2012

Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer

Read more
Nov 7, 2012

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012

Read more
Oct 24, 2012

Insmed to Host 2012 Third Quarter Earnings Conference Call

Read more
Sep 28, 2012

Insmed Announces Pricing of Approximately $26 Million Direct Public Offering

Read more
Aug 30, 2012

Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference

Read more
Aug 14, 2012

Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

Read more
Aug 7, 2012

Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012

Read more
Aug 6, 2012

Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation